[EN] STEROID-DERIVED CYCLOPAMINE ANALOGS AND METHODS FOR USING THE SAME IN THE PREVENTION OR TREATMENT OF CANCER [FR] ANALOGUES DE CYCLOPAMINE DÉRIVÉS DE STÉROÏDE ET PROCÉDÉS D'UTILISATION DE CES DERNIERS DANS LA PRÉVENTION OU LE TRAITEMENT DU CANCER
[EN] STEROID-DERIVED CYCLOPAMINE ANALOGS AND METHODS FOR USING THE SAME IN THE PREVENTION OR TREATMENT OF CANCER<br/>[FR] ANALOGUES DE CYCLOPAMINE DÉRIVÉS DE STÉROÏDE ET PROCÉDÉS D'UTILISATION DE CES DERNIERS DANS LA PRÉVENTION OU LE TRAITEMENT DU CANCER
申请人:WISTAR INST
公开号:WO2009058945A1
公开(公告)日:2009-05-07
The present invention relates to steroid-derived cyclopamine analogs and methods for using the same for inhibiting sonic hedgehog signaling and preventing or treating cancer. A method for synthesizing the analogs of the present invention from a steroid is also provided.
Steroid-Derived Cyclopamine Analogs and Methods for Using the Same in the Prevention or Treatment of Cancer
申请人:Dahmane Nadia
公开号:US20100298281A1
公开(公告)日:2010-11-25
The present invention relates to steroid-derived cyclopamine analogs and methods for using the same for inhibiting sonic hedgehog signaling and preventing or treating cancer. A method for synthesizing the analogs of the present invention from a steroid is also provided.
US8575141B2
申请人:——
公开号:US8575141B2
公开(公告)日:2013-11-05
US8669243B2
申请人:——
公开号:US8669243B2
公开(公告)日:2014-03-11
Studies Directed toward the Elucidation of the Pharmacophore of Steroid-Based Sonic Hedgehog Signaling Inhibitors
作者:André K. Isaacs、Chaomei Xiang、Valérie Baubet、Nadia Dahmane、Jeffrey D. Winkler
DOI:10.1021/ol202020c
日期:2011.10.7
Previous work from our laboratory has established that the readily available steroid-based analog 2 of cyclopamine 1 is, like 1, a highly potent inhibitor of Hedgehog signaling. The first structure-activity relationship studies on 2, i.e., the synthesis and biological evaluation of both the C-17 epi analog 4 and the C-3 deoxy analog 11, both of which are more potent than cyclopamine 1, are described. The implications of these results for the emerging pharmacophore of these Sonic Hedgehog signaling inhibitors are discussed.